This article has been cited by
1A Comparison of Nephrotoxicity in Non–Intensive Care Unit Medical/Surgical Patients Receiving Vancomycin Alone Versus Vancomycin With Piperacillin-Tazobactam—Do We Need to Ban This Combination ?
Paul M. Tulkens
Infectious Diseases in Clinical Practice.2018;26(1)1
[DOI]
2Incidence and Risk Factors for Development of Thrombocytopenia in Patients Treated With Linezolid for 7 Days or Greater
Alyssa D. Rabon,Jon P. Fisher,Shawn H. MacVane
Annals of Pharmacotherapy.2018;52(11)1162
[DOI]
3Comparative Evaluation of Linezolid and Teicoplanin in the Treatment of Ventilator-Associated MRSA Pneumonia: A Single-Center Experience
Md Jahidul Hasan,Shahzadi Sayeeda Tun Nessa,Raihan Rabbani
International Journal of Infection.2020;7(3)1162
[DOI]
4Antibacterial synergy between linezolid and baicalein against methicillin-resistant Staphylococcus aureus biofilm in vivo
Tangjuan Liu,Jing Luo,Guan Bi,Zhongye Du,Jinliang Kong,Yiqiang Chen
Microbial Pathogenesis.2020;147(3)104411
[DOI]
5A retrospective cohort study to screen linezolid-induced thrombocytopenia in adult patients hospitalized in the Midwestern Region of Brazil
Letícia Souza Lima,Eliana da Costa Alvarenga Brito,Karine Mattos,Eduardo Benedetti Parisotto,Renata Trentin Perdomo,Simone Schneider Weber
Hematology, Transfusion and Cell Therapy.2020;42(3)230
[DOI]
  Feedback 
  Subscribe